Skip to main content
. 2020 Nov 3;13(6):e003133. doi: 10.1161/CIRCGEN.120.003133

Figure 2.

Figure 2.

Recontact, clinical follow-up, and return of results for p.T224M KCNQ1 carriers. Of the124 carriers offered return of results, 88 (71% of those who received initial letter, 86% of those who responded) were enrolled. All 88 participants received their results with individualized clinical recommendations.